Find N-Phenylacetyl-L-Prolylglycine Ethyl Ester manufacturers, exporters & distributors on PharmaCompass

N-Phenylacetyl-L-Prolylglycine Ethyl Ester

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 Listed Suppliers, $ API Reference Price

3 API Suppliers
3 Listed Suppliers
$ API Reference Price

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 655

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 157115-85-0, Gvs-111, Omberacetam, (s)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate, N-phenylacetyl-l-prolylglycine ethyl ester, Glycine, 1-(phenylacetyl)-l-prolyl-, ethyl ester

Molecular Formula

C₁₇H₂₂N₂O₄

Molecular Weight

318.4 g/mol

InChI Key

PJNSMUBMSNAEEN-AWEZNQCLSA-N

FDA UNII

4QBJ98683M

1 2D Structure

N-Phenylacetyl-L-Prolylglycine Ethyl Ester

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate

2.1.2 InChI

InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1

2.1.3 InChI Key

PJNSMUBMSNAEEN-AWEZNQCLSA-N

2.1.4 Canonical SMILES

CCOC(=O)CNC(=O)C1CCCN1C(=O)CC2=CC=CC=C2

2.1.5 Isomeric SMILES

CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2

2.2 Other Identifiers

2.2.1 UNII

4QBJ98683M

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Dvd-111

2. Ethyl Phenylacetyl-pro-gly

3. Gvs 111

4. Gvs-111

5. N-phenylacetyl-l-prolylglycine Ethyl Ester

6. Omberacetam

7. Sgs-111

2.3.2 Depositor-Supplied Synonyms

1. 157115-85-0

2. Gvs-111

3. Omberacetam

4. (s)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate

5. N-phenylacetyl-l-prolylglycine Ethyl Ester

6. Glycine, 1-(phenylacetyl)-l-prolyl-, Ethyl Ester

7. Ethyl 2-[[(2s)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate

8. 4qbj98683m

9. N-(1-(phenylacetyl)-l-prolyl)glycine Ethyl Ester

10. Ethyl (2-phenylacetyl)-l-prolylglycinate

11. Ethyl 1-(phenylacetyl)-l-prolylglycinate

12. Gvs 111

13. N-[1-(phenylacetyl)-l-prolyl]glycine Ethyl Ester

14. Ethyl Phenylacetyl-pro-gly

15. Unii-4qbj98683m

16. Glycine, N-(1-(phenylacetyl)-l-prolyl)-, Ethyl Ester

17. Omberacetam [inn]

18. Noopept [who-dd]

19. Schembl194807

20. Glycine, 1-(2-phenylacetyl)-l-prolyl-, Ethyl Ester

21. Noopept, >=98% (hplc)

22. Chembl4303687

23. Dtxsid80166214

24. Dvd-111

25. Sgs-111

26. Zinc3812682

27. Akos016012268

28. Am84514

29. Cs-1575

30. Ncgc00378939-05

31. As-10555

32. Hy-17456

33. J759.455k

34. N1120

35. Ethyl N-[1-(phenylacetyl)-l-prolyl]glycinate

36. 1-(2-phenylacetyl)-l-prolylglycine Ethyl Ester

37. C72975

38. 115p850

39. Q7049784

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₂₂N₂O₄
Molecular Weight	318.4 g/mol
XLogP3	1.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	7
Exact Mass	318.15795719 g/mol
Monoisotopic Mass	318.15795719 g/mol
Topological Polar Surface Area	75.7 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	432
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Neuroprotective Agents

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)

API SUPPLIERS